MetaCap

Obsidian Therapeutics Statistics

NASDAQ: OBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.00-0.15 (-1.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Obsidian Therapeutics by the numbers

Obsidian Therapeutics has a market capitalization of $741.3 million based on 61.77M shares outstanding. With trailing EPS of $-6.52, Obsidian Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.5% below its 50-day average and 27.0% below its 200-day average.

Average daily trading volume is 511.50K shares, or about $6.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

OBX valuation vs. peer median

OBX compared with the median of 8 peer companies
MetricOBXPeer medianDifference
Market cap$741.29M$766.56M-3%
Avg. volume511.50K2.28M-78%

Peer median across 8 companies: IVA, ARDX, RIGL, ORIC, COLL, IRWD, SNDX, VSTM.

Valuation

Price and trading

Previous close
12.15
Open
12.22
Day range
11.76 – 12.30
52-week range
9.60 – 49.97
Beta
—
Volume
336.50K

Dividends and events

Additional statistics

Market Cap
741.29M
Forward Pe
-5.63
Eps
-6.52
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
49.97
Week52 Low
9.60
Avg Volume
511.50K
Shares Outstanding
61.77M
Ma50
13.72
Ma200
16.43
Pct From52w High
-75.99%
Pct From52w Low
25.00%

Related